Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib before or after surgery in metastatic renal cell carcinoma
NCT00626509Phase 2Unknown
- Sponsor
- Gruppo Italiano Carcinoma Renale
- Start
- Feb 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Gruppo Italiano Carcinoma Renale. Status: unknown.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00626509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626509.